Spero Therapeutics to Present Data for All Pipeline Programs at IDWeek 2020
CAMBRIDGE, Mass., Oct. 16, 2020 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, […]